Key result
Calcium channel blockers lead antihypertensive prescriptions in hypertensive CKD patients with ~91% utilization.
Why the study?
Achieving target blood pressure under 140/90 mmHg in patients with hypertension and chronic kidney disease is challenging, necessitating evaluation of safe and effective drug therapy patterns.
Observational (n=70)
No
Answers are grounded in this paper and cite their sources.
In a cohort of hypertensive CKD patients, calcium channel blockers were the most commonly prescribed antihypertensives, with dual and triple therapy aligning with ESH guidelines.
Introduction: Hypertension is a chronic illness associated with high morbidity & mortality, with a rising number of patients with hypertension and chronic kidney disease, achieving blood pressure of less than 140/90 mm of Hg is challenging.Hence, there is a need for appropriate, safe, effective and economical study to find out the patterns of drug therapy.Objectives: To evaluate utilization patterns of antihypertensive agents in chronic kidney disease patients.Methodology: A prospective observational study was conducted for a period of 6 months in Jayanagar General Hospital, Bengaluru.We included 70 hypertensive CKD patients.Detailed patient information data were noted, and data entered in a preformed proforma in Microsoft Excel sheet for compilation and subjected to statistical analysis.Results: Total 70 case records of patients having chronic kidney disease were analysed.Mean age was 52.08 ± 15.14.CKD was more prevalent in males 38 (54.2%) and 32 (46.8%) females with male to female ratio of 2.3:2.Most of the patients (52.80%) belonged tote age group of 41-60 years.Among the anti-hypertensive agents, most frequently used was calcium channel blockers (91.4%), followed by diuretics (54.2%),Beta blockers (31.4%), alpha blockers, ACE inhibitors and ARB.Conclusion: Dual and triple therapy were prescribed which was according to ESH guidelines.This study highlights some therapeutic rationality in this health centre.However,
No takes yet. Share an insight, caveat, or question.
Amish Uprety (2019) conducted an observational in Hypertension and Chronic Kidney Disease (n=70). Antihypertensive drugs was evaluated on Utilization patterns of antihypertensive agents. Among 70 hypertensive patients with chronic kidney disease, calcium channel blockers were the most frequently prescribed antihypertensive agents (91.4%), with 67.1% adherence to ESH guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: